WST | tickerfilter.com

Fundamental analysis

61%

Profitability 69%

Dept financing 19%

Liquidity 75%

Performance 60%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

3.58%

1 Month

4.78%

3 Months

-4.64%

6 Months

-12.12%

1 Year

-23.21%

2 Year

6.26%

Key data

Stock price

$313.63

P/E Ratio

43.34

DAY RANGE

$311.97 - $319.76

EPS

$7.04

52 WEEK RANGE

$264.82 - $413.20

52 WEEK CHANGE

-$0.23

MARKET CAP

22.751 B

YIELD

0.25%

SHARES OUTSTANDING

72.542 M

DIVIDEND

$0.20

EX-DIVIDEND DATE

07/31/2024

NEXT EARNINGS DATE

10/24/2024

BETA

0.88

PUBLIC FLOAT

AVERAGE 10 VOLUME

$379,604

AVERAGE 30 VOLUME

$463,593

Company detail

CEO: Eric Green
Region: US
Website: https://www.westpharma.com/
Employees: 4,483
IPO year: -

Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.

WST - West Pharmaceutical Services, Inc.